NASDAQ: COGT
Cogent Biosciences Inc Stock Ownership - Who owns Cogent Biosciences?

Insider buying vs selling

Have Cogent Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cole PinnowChief Commercial Officer2025-01-1443,750$7.60
$332.41kBuy

1 of 1

COGT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COGT insiders and whales buy or sell their stock.

COGT Shareholders

What type of owners hold Cogent Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC15.00%17,077,329$123.47MInstitution
Kynam Capital Management LP8.00%9,105,000$65.83MInstitution
Paradigm Biocapital Advisors LP7.87%8,963,655$64.81MInstitution
Commodore Capital LP7.81%8,892,816$64.30MInstitution
Blackrock Inc7.18%8,175,527$59.11MInstitution
Tcg Crossover Management LLC6.12%6,964,375$50.35MInstitution
Fairmount Funds Management LLC5.47%6,225,641$45.01MInsider
Fairmount Funds Management LLC5.47%6,225,641$45.01MInstitution
Vanguard Group Inc5.32%6,058,338$43.80MInstitution
Vr Adviser LLC4.99%5,684,411$41.10MInstitution

1 of 3

COGT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COGT90.95%9.05%Net Buying
SNDX91.93%8.07%Net BuyingNet Buying
LENZ41.04%58.96%Net SellingNet Selling
ARDX42.07%57.93%Net BuyingNet Buying
MDXG45.75%54.25%Net SellingNet Buying

Cogent Biosciences Stock Ownership FAQ

Who owns Cogent Biosciences?

Cogent Biosciences (NASDAQ: COGT) is owned by 117.24% institutional shareholders, 11.66% Cogent Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Cogent Biosciences shareholder, owning 6.23M shares representing 5.47% of the company. Fairmount Funds Management LLC's Cogent Biosciences shares are currently valued at $45.01M.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.